1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7076)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (296)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22468)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for relapsed neuroblastoma resistant to salvage therapy: A phase II trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for consolidating >= 2nd complete remission of high-risk neuroblastoma
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Clinical impact of ALK mutations in neuroblastoma
    Meeting Abstract

    O'Donohue, T.; Gulati, N.; Shukla, N.; Roberts, S.; Basu, E.; Kushner, B.; Cheung, N. K.; Modak, S.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Clonal evolution in metastatic rhabdomyosarcoma
    Meeting Abstract

    Kinnaman, M.; Makohon-Moore, A.; Bouvier, N.; Glodzik, D.; Levine, M.; Papaemmanuil, E.; Dela Cruz, F.; Wexler, L.; Kung, A.; Iacobuzio-Donahue, C.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Prognostic significance of ATRX aberrations in neuroblastoma
    Meeting Abstract

    Miltiadous, O.; Kushner, B.; Cheung, N. K.; Shukla, N.; Modak, S.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • A curative approach to central nervous system metastases of neuroblastoma
    Meeting Abstract

    Kramer, K.; Kushner, B.; Modak, S.; Pandit-Taskar, N.; Mauguen, A.; Tomlinson, U.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Preliminary results of "HITS" pilot/phase II study
    Meeting Abstract

    Modak, S.; Kushner, B.; Flores, M.; Santa-Maria, V.; Garraus, M.; Basu, E.; Roberts, S.; Castaneda, A.; Gorostegui, M.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • CAR T-cells followed by CD34-selected T-cell depleted (TCD) ALLO-HSCT is associated with low toxicity and favorable overall survival
    Meeting Abstract

    Fabrizio, V.; Boulad, F.; Cancio, M.; Margossian, S.; Mauguen, A.; Prockop, S.; Scaradavou, M.; Shah, N.; Spitzer, B.; Stieglitz, E.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Association of BAP1 alterations with malignant pleural mesothelioma treated with trimodality therapy
    Meeting Abstract

    Zauderer, M. G.; Rizvi, H.; DuBoff, M. A.; Adusumilli, P. S.; Rusch, V. W.; Sauter, J. L.; Ladanyi, M.; Rimner, A.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Phase I study of OKT3 x hu3F8 bispecific antibody (GD2Bi) armed T cells (GD2BATs) in GD2-positive tumors
    Meeting Abstract

    Yankelevich, M.; Modak, S.; Chu, R.; Lee, D. W.; Thakur, A.; Cheung, N. K. V.; Lum, L. G.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save